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Abstract 
 
Background. The study of iron metabolism is essential in nutritional sciences as iron deficiency is one 
of the most common nutritional deficiencies in humans, and represents a serious health problem 
worldwide. The mouse is utilized as a unique and powerful model for the identification and 
characterization of genes involved in iron metabolism, and for studying the pathogenesis of iron 
disorders. Thus, sophisticated and sensitive techniques have been developed to study iron metabolism 
in this animal model. In particular, iron absorption has been studied in mice by using the radioisotopes 
55Fe and 59Fe in tied-off or dissected and everted duodenal segments. Nevertheless, several drawbacks 
discourage the extended use of these approaches. 
Methods and Results. Here we report the use of the stable isotope 57Fe to measure iron absorption in 
mice. We show that after oral administration of 57Fe-containing solutions it is possible to measure both 
duodenal iron retention and duodenal iron transfer to specific organs, using inductively coupled plasma 
mass spectrometry (ICP-MS). As 57Fe is administered orally, no surgical operation is needed before the 
end of the experiment, thus allowing the measurement of iron absorption under physiologic conditions. 
Moreover, the use of ICP-MS for 57Fe detection ensures high sensitivity and provides quantitative data. 
Finally, the use of a stable isotope enables the measurement of both iron absorption and histologic 
and/or biochemical analyses in the same animal.  
Conclusions. The use of 57Fe to measure iron absorption in mice therefore represents an alternative to 
radioisotope-based methods, providing a new tool to extend our knowledge on the mechanism of iron 
absorption.  
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Introduction 
 
Iron is an essential nutrient for all forms of life as it participates in many biological processes, 
including oxygen transport, as well as behaving as a cofactor to several enzymes. In humans, iron 
deficiency represents a common health problem both in Western and developing countries. The main 
causes of iron deficiency are poor absorption of iron by the body, inadequate daily intake of iron, 
pregnancy, growth spurts or blood loss due to trauma, infection, malaria or hematological disorders. 
Conversely, iron is toxic when in excess, and therefore body iron levels are tightly regulated. As the 
body cannot actively excrete iron, the body iron content is regulated at the absorption step when it is 
taken up by duodenal villus enterocytes. Main stimuli for iron absorption are represented by changes in 
body iron stores, and according to the requirements of the developing erythroid mass [1].  
Most of our knowledge on iron homeostasis relies on studies carried out on mice. Several genetic 
models are available, including both natural and gene targeting-generated mutations of the main genes 
involved in iron absorption, recycling, storage and utilization [2,3,4,5,6]. The mouse also represents a 
unique model to identify novel players in iron homeostasis [7,8,9]. Finally, it has been shown that the 
occurrence, in mice, of genetic mutations responsible for human iron disorders, for example 
hemochromatosis and anemia, fully recapitulate the human diseases, thus stressing the importance of 
mouse models for studying the pathogenetic mechanisms of these diseases and for testing new 
therapies [10,11].  
Up until now, iron absorption has been measured in mice by using the tied-off duodenal technique 
along with the radioisotopes 55Fe and 59Fe [12,13]. 55Fe is a beta emitter which allows the 
determination of mucosal uptake after administration of an oral dose of iron or incubation of a 
duodenal segment in the presence of the radioisotope, whereas 59Fe is a gamma and beta emitter that, 
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besides measurement of mucosal uptake, enables the determination of iron transferred from the 
duodenum to the rest of the body. The main disadvantage of using 59Fe is that gamma emissions have a 
significant penetrating and shallow external exposure hazard, thus requiring laboratories specifically 
equipped for handling animals treated with this isotope. Here we report an alternative approach to 
assess iron uptake and distribution in mice, based on the use of the stable iron isotope 57Fe, detected by 
inductively coupled plasma mass spectrometry (ICP-MS). 57Fe is one of the four naturally-occurring 
isotopes of iron, and accounts for 2.119% of total iron, the other isotopes being 54Fe (5.845%), 56Fe 
(91.754%) and 58Fe (0.282%) [14]. Natural iron isotope variations in the blood may serve to identify 
differences in intestinal iron absorption between individuals and genotypes [15]. Moreover, 57Fe and 
58Fe have already been used as tracers in nutritional studies on humans due to their low natural 
abundance [16,17,18].  
Herein a procedure is reported to assess both duodenal mucosal retention and mucosal transfer of  57Fe  
to specific organs, following administration of an oral dose of  57Fe in mice. 
 
Materials and methods 
 
Animals 
Wild-type and Hfe-null mice [19] in the 129Sv genetic background were fed on a standard diet (4RF25 
GLP, Mucedola, Settimo Milanese, Milano, Italy) containing 8 mg/kg and 292 mg/kg heme-iron and 
inorganic iron respectively, and received water ad lib. In the low-iron experiments, mice were given a 
AIN93G iron-deficient diet (Mucedola, Settimo Milanese, Milano, Italy) containing 54 mg/kg total iron 
for 2 weeks. 
All experiments were approved by the animal ethical committee of the University of Torino (Italy). 
 6 
 
Treatment 
The stable iron isotope 57Fe  (57Fe at 94% enrichment; Frontier Scientific Inc., Logan, Utah USA) was 
used as tracer. A 0.4 mol/L solution of 57FeSO4 was prepared by overnight dissolution of 22.85 g 
57Fe/L in 0.4 mol/L H2SO4 (Sigma Aldrich, Milano, Italy). The obtained 57FeSO4 solution was stored at 
4°C. Before its use, 87.7 mg sucrose and 0.83 mg ascorbic acid per mg iron were added to the 57FeSO4 
solution to yield to a final concentration of  20 mmol/L57Fe, 5.38 mmol/L ascorbic acid and 10% 
sucrose .  
As a negative control, an analogous solution with no tracer was prepared.  
Both the 57Fe-labelled and the control solution were adjusted to pH7 by adding the required volume of 
1 mol/L NaOH. To assess the in vivo tissue absorption of 57Fe after oral administration of 57Fe-
containing solutions, overnight-fasted mice were orally treated with 20 µl of 57Fe-labelled solution. 
Control mice received vehicle solutions. During treatment, mice received water ad lib. Tissues were 
collected at varying times following treatment. Control mice represented the “0” time point of the 
treatment. 
 
Tissue Collection 
 Mice were anaesthetized with Avertin (2,2,2-tribromoethanol; Sigma-Aldrich, Milano, Italy) at a dose 
of 2 mg/kg body weight . 
Blood was collected from mice by cardiac puncture. Briefly, following a wash in heparin-containing 
solution, the needle of a syringe was inserted at the base of the sternum into the thoracic cavity and 
ventricular blood was slowly withdrawn. Samples were then centrifuged at 4000 rpm for 6 minutes and 
supernatants were recovered, weighed and stored at -20°C prior to proceeding with the analyses. 
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Duodenums, livers and kidneys were excised after transcardial perfusion of mice with 0.1 mol/L 
phosphate-buffered saline (PBS), washed in PBS, blotted dry, weighed and stored at -20°C prior to 
analyses. Tissue perfusion with PBS was necessary to reduce background signal in ICP-MS 
measurements of 57Fe absorption, considering the high amount of physiological iron present in blood. 
Bone marrow was obtained from the hind legs of the mice. Briefly, immediately before surgery, mice 
were sacrificed. Tibias and femurs were dissected from surrounding muscles and tendons, and flushed 
with PBS by inserting the needle of a syringe into the ends of the bones. The flow-through was then 
centrifuged at 1200 rpm for 5 minutes and the pellet was weighed and stored at -20°C prior to 
proceeding with sample analyses. 
 
Tissue analyses by ICP-MS 
57Fe isotope and total Fe were determined using inductively coupled plasma mass spectrometry (ICP-
MS) (Element-2; Thermo-Finnigan, Rodano (MI), Italy) at medium mass resolution (M/∆M ~4000). 
This resolution is unable to eliminate isobaric interferences of 54Cr and 58Ni on 58Fe and 54Fe isotopes. 
For this reason the isotope 57Fe was selected as tracer. Sample digestion was performed with 2 ml of 
concentrated HNO3 (70%) by means of microwave heating at 160°C for 20 minutes (Milestone 
MicroSYNTH Microwave labstation equipped with an optical fiber temperature control and HPR-
1000/6M six position high-pressure reactor, Bergamo, Italy). After digestion, the volume of each 
sample was brought to 3 ml with ultrapure water and the sample was analyzed by ICP-MS.  A natural 
abundance iron standard solution was analyzed during sample runs in order to check changing in the 
systematic bias. The calibration curve was obtained using four iron absorption standard solutions 
(Sigma-Aldrich) in the range 0.2–0.05 µg/ml.  
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Calculations 
After treatment with 57Fe-labelled or control solution, the amount (expressed as µg of iron per g of wet 
tissue) of total iron (totFe) and of 57Fe isotope was determined for each tissue of interest by ICP-MS. 
For each tissue, the calculated amount of naturally-occurring 57Fe  was subtracted from the measured 
value in order to get a measure of the amount of iron retained by the tissue upon the treatment with 
57Fe-labelled solution. The amount of naturally-occurring 57Fe was calculated considering the average 
percentage of 57Fe under basal conditions (%57Fe) in wild-type mice with respect to total iron observed 
(totFe), as shown in the example reported in Table 1.     
 
Tissue iron measurement by colorimetric method 
For tissue iron determination by colorimetric measurement, the BPS-based method was performed, 
using 4,7-diphenyl-1,10-phenantroline disulphonic acid (BPS) as chromogen [20]. Briefly, 0,1 g of dry 
tissue was incubated overnight in a mixture of trichloroacetic (10%) and hydrochloric (3 N) acids, and 
20 µl of supernatant reduced with thioglycolic acid (Sigma-Aldrich, Milano, Italy) and acetic acid-
acetate buffer (pH 4.5). Ferrous iron content was determined spectrophotometrically at 535 nm 
following the addition of BPS and incubation for 1 hour at 37°C.  
 
Statistical Analysis 
Results were expressed as mean ±SEM. Statistical analyses were performed using one-way or two-way 
analysis of variance followed by the Bonferroni correction for multiple group comparisons. An 
unpaired Student’s t-test was used when only two groups were compared. A P value of less than 0.05 
was regarded as significant.  
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Results 
 
Assessment of  natural abundance of 57Fe in mouse tissues 
The preliminary experimental work for the 57Fe method in mice is summarized as follows. 
Firstly, after defining the experimental set-up for tissue collection (for details see “Materials and 
methods”), the reliability of total iron and 57Fe detection by mass spectrometry in samples recovered 
from wild-type mice at basal conditions was assessed. Duodenum, liver and kidney tissues were 
dissected and subjected to ICP-MS and spectrophotometric analyses.  
A good correlation between iron levels measured by mass spectrometry, and the standard colorimetric 
method using BPS as a chromogen (Figure 1A) was found. As expected total liver iron in Hfe-null 
mice suffering from hemochromatosis resulted as being significantly higher than in wild-type animals 
(Figure 1B). 
In wild-type mice, the amount of 57Fe with respect to total iron (%57Fe
 
/totFe) was constant in the 
different tissues analyzed, i.e serum, duodenum, liver, kidney and bone marrow, and reached a value of 
about 2.3%, very close to the reported natural percentage of 57Fe in the earth [14] (Figure 1C).   
 
Measurement of 57Fe retention by duodenal mucosa after oral iron administration 
The relatively low natural abundance of 57Fe offers the possibility of exploiting this isotope as an easy 
detectable tracer upon an oral administration of solutions enriched in 57Fe.  
To assess the in vivo uptake of 57Fe by the duodenal mucosa after oral administration of 57Fe-
containing solutions, 2-month old wild-type mice were treated with 20 µl of a solution containing 57Fe, 
and duodenum tissue was collected at different times following the treatment. A comparable volume of 
vehicle solution was given to control mice.  
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Thirty minutes after treatment, a considerably high amount of 57Fe was detected in the duodenal 
mucosa of treated mice compared to controls, and the quantity of 57Fe retained by duodenum further 
increased ninety minutes after the oral administration (Figure 2A).  
We used Hfe-null mice as positive controls, known to have enhanced duodenal iron uptake [19], and 
wild-type mice fed with an iron deficient diet for 2 weeks, that display increased expression of 
duodenal iron transporters [21]. When 57Fe was administered to Hfe-null mice, at sixty minutes 
following treatment, the amount of 57Fe detected in the duodenal mucosa was already higher than in 
wild-type animals (Figure 2B).  The same was observed in wild-type mice fed on an iron-deficient diet 
(Figure 2C). 
 
Determination of the amount of 57Fe delivered to different organs  
After uptake from the duodenal lumen, iron captured by enterocytes is usually partly stored in ferritins, 
and partly exported into the bloodstream through a process involving the iron exporter ferroportin1, 
located at the basal membrane of enterocytes. Once in the circulation, iron is captured by the iron 
carrier transferrin and transported to peripheral organs, primarily to the bone marrow [1,22].   
To test the possibility that orally administered 57Fe absorbed by the duodenum and subsequently 
delivered to peripheral organs could be detected by mass spectrometry analyses, we treated wild-type 
mice as described above and collected the livers and bone marrow at different times following 
treatment. A slight increase in 57Fe levels in the liver was already evident 30 minutes after 
administration of iron, and further increased up to 90 minutes following treatment (Figure 3A). 
Furthermore, two days after treatment, a significant amount of tracer was detected in the bone marrow 
(Figure 3B). On the other hand, the transfer of 57Fe to the kidney, an organ only marginally involved in 
iron handling, was negligible compared to the liver and bone marrow (Figure 3C).  
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As expected, the transfer of 57Fe to the liver of Hfe-null mice and of wild-type mice fed on an iron-
deficient diet was strongly enhanced compared to wild-type animals and well detectable 60 minutes 
after oral administration of iron-containing solutions (Figure 3D and 3E).  
 
Discussion 
 
In this work a novel procedure to measure iron absorption in mice using the stable 57Fe isotope has 
been described.  
Upon administration of an oral dose of a 57Fe-containing solution, a considerably high amount of 57Fe 
was detected in the duodenal mucosa of mice. Moreover, the transfer of a significant amount of 57Fe to 
peripheral organs, such as the liver and bone marrow was assessed. As stable iron isotopes exist in 
nature in fixed ratios, corrections have to be made for background levels when they are used as tracers 
in absorption studies. For this purpose, corrections for the natural abundance of the stable isotope 57Fe 
have been considered during the analysis of experiments. Moreover, a series of controls, such as the 
assessment of iron absorption in Hfe-null mice, and in animals fed on an iron-deficient diet, confirmed 
the reliability of the proposed method. The sensitivity of the ICP-MS technique allows detection of 
relatively low amounts of 57Fe corresponding to an experimental detection limit of about 40 ng 57Fe/g 
tissue. 
The procedure described in the present work therefore represents a good technique to assess iron 
absorption in mice and, along with the classical methods, allows determination of both mucosal 
retention and mucosal transfer of iron, distinguishing between the two steps of iron absorption, thus 
offering a valuable alternative to the approaches that have been used in laboratory practices so far. 
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The use of orally administered 57Fe to measure iron absorption in mice shows a series of advantages 
respect to other techniques reported in the literature [23]. 
Firstly, the use of a stable iron isotope instead of a radioactive one shows obvious benefits in terms of 
safety and ease of handling, as the use of 57Fe does not require special laboratory equipment or 
particular skills for the operator.    
Secondly, the cost of 57Fe-enriched substances is considerably lower than that of radioactive iron-
containing compounds, thus representing an affordable tracer for many research centres.  
Moreover, the use of ICP-MS for 57Fe detection ensures high sensitivity and the use of a calibration 
curve during measurements provides quantitative data.  
Another advantage associated with the herein reported method deals with the possibility of carrying out 
several kinds of analyses on the tissue specimen recovered from animals treated with 57Fe. Indeed, the 
limited handling of the mouse during the experiment, and the safety of the employed tracer allow the 
use of excised tissues partly for ICP-MS analyses and partly for any other kind of tests, i.e. biochemical  
and histological analyses.  
Finally, while radioactive tracers are not suitable for multi-element studies because of difficulties due 
to overlapping energy spectra, the absorption of different stable isotopes can be measured by ICP-MS 
simultaneously. 
A weak point of this methodology is the impossibility to detect the amount of absorbed iron in the 
entire carcass, which the use of radioactive compound allows [24,25,26]. Of course, separated analyses 
on different organs of interest can be performed in order to reach a global assessment of iron 
distribution in the entire organism. 
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In conclusion, the present work proposes a sensitive, safe, and reliable method to measure iron 
absorption in mice, thus providing an alternative technique to that reported so far and offering a new 
methodology to improve the study of iron absorption mechanisms.   
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Table 1. Calculation of  57Fe retention in tissues. An example is given considering a measurement of 
20 µg/g for total iron and of 5 µg/g for 57Fe. The calculated amount of naturally occurring 57Fe was 
subtracted from the measured value in order to get a measure of the amount of iron retained by the 
tissue upon treatment with the 57Fe-labelled solution. 
 
 
medium %57Fe 
 under basal 
conditions 
totFe (µg/g) 
observed after 
treatment 
57Fe (µg/g) observed 
after treatment 
expected naturally 
occurring 57Fe (µg/g)   
57Fe retained 
(57Fe observed -57Fe expected) 
2.4% 20 5 0.48  
(2.4% of 20) 
5 – 0.48 = 4.52 
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Figure Legends 
 
Figure 1. Assessment of naturally-occurring total iron and 57Fe in mouse tissues. (A) Total tissue 
iron content in the duodenum, liver and kidney of 2 month-old wild-type mice, measured by the BPS-
based colorimetric method or by ICP-MS. Data represent mean ± SEM; n=10. (B) Total iron content in 
the liver of 2 month-old wild-type and Hfe-null mice measured by ICP-MS. Values are expressed as µg 
iron/g tissue. Data represent mean ± SEM; n=5; ***=P<0.001. (C) Percentage of naturally-occurring 
57Fe in different wild-type tissues. Values are expressed as a percentage of 57Fe with respect to total 
iron. Data represent mean ± SEM; n=9. 
 
Figure 2. Measurement of 57Fe retention in the duodenal mucosa after oral treatment. (A) 57Fe 
retention in the duodenal mucosa of wild-type mice measured by ICP-MS 30, 60 and 90 minutes after 
oral treatment with a solution containing 20 mmol/L 57Fe. Control mice were treated with a vehicle 
solution and represented the “0” time point of the treatment in the experiment. Values are expressed as 
µg 57Fe/ g tissue. Data represent mean ± SEM; n=9 for each experimental point; *=P<0.05, 
***=P<0.001. (B) 57Fe retention in the duodenal mucosa of wild-type and Hfe-null mice measured by 
ICP-MS 60 minutes after oral treatment with a solution containing 20 mmol/L 57Fe. Control wild-type 
and Hfe-null mice were treated with a vehicle solution and represented the “0” time point of the 
treatment in the experiment. Values are expressed as µg 57Fe/ g tissue. Data represent mean ± SEM; 
n=4 for each experimental point; *=P<0.05, **=P<0.01 (comparing control mice with the 
corresponding group of 57Fe-treated mice), #=P<0.05 (comparing the two genotypes). (C) 57Fe 
retention in the duodenal mucosa of wild-type mice fed a standard or an iron-free (IF) diet, measured 
by ICP-MS 60 minutes after oral treatment with a solution containing 20 mmol/L 57Fe. Control mice 
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were treated with a vehicle solution and represented the “0” time point of the treatment in the 
experiment. Values are expressed as µg 57Fe/ g tissue. Data represent mean ± SEM; n=4 for each 
experimental point; ***=P<0.001 (comparing control mice with the corresponding group of 57Fe-
treated mice), ###=P<0.001 (comparing mice fed on the two different diets). 
 
Figure 3. Determination of the amount of 57Fe delivered to different organs. (A,C) 57Fe retention in 
the liver (A) or in the kidney (C) of wild-type mice measured by ICP-MS 30, 60 and 90 minutes after 
oral treatment with a solution containing 20 mmol/L 57Fe. Control mice were treated with a vehicle 
solution and represented the “0” time point of the treatment in the experiment. Values are expressed as 
µg 57Fe/ g tissue. Data represent mean ± SEM; n=9 for each experimental point; **=P<0.01. (B) 57Fe 
retention in the bone marrow of wild-type mice measured by ICP-MS 48 hours after oral treatment with 
a solution containing 20 mmol/L 57Fe. Control mice were treated with a vehicle solution and 
represented the “0” time point of the treatment in the experiment. Values are expressed as µg 57Fe/ g 
tissue. Data represent mean ± SEM; n=9 for each experimental point; *=P<0.05. (D) 57Fe retention in 
the liver of wild-type and Hfe-null mice measured by ICP-MS 60 minutes after oral treatment with a 
solution containing 20 mmol/L 57Fe. Control wild-type and Hfe-null mice were treated with vehicle 
solution and represented the “0” time point of the treatment in the experiment. Values are expressed as 
µg 57Fe/ g tissue. Data represent mean ± SEM; n=4 for each experimental point; *=P<0.05 (comparing 
control mice with the corresponding group of 57Fe-treated mice), ###=P<0.001 (comparing the two 
genotypes). (E) 57Fe retention in the liver of wild-type mice fed a standard or an iron-free (IF) diet 
measured by ICP-MS 60 minutes after oral treatment with a solution containing 20 mmol/L 57Fe. 
Control mice were treated with a vehicle solution and represented the “0” time point of the treatment in 
the experiment. Values are expressed as µg 57Fe/ g tissue. Data represent mean ± SEM; n=4 for each 
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experimental point; **=P<0.01 (comparing control mice with the corresponding group of 57Fe-treated 
mice), ##=P<0.01 (comparing mice fed on the two different diets). 
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